ESO-T01
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ESO-T01, covering 2025-02-11 to 2025-03-25. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma. [EARLY_Phase 1]